1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Arcoma AB

Arcoma AB

ARCOMA.ST
Arcoma ABSE flagStockholm Stock Exchange
8.22
SEK
-0.18
- -
117.62MMarket Cap
Arcoma AB
ARCOMA.ST
(Stockholm Stock Exchange)

Recent

price

8.22

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1.7
1.25
1,504.48
11.85
9.87
7.87
9.45
10.57
9.22
9.05
9.48
12.36
11.89
9.14
10.23
Revenue per Share
-0.04
-0.16
10.54
-0.62
-1.13
-0.84
-0.13
0.52
0.11
-0.58
0.14
0.19
0.85
0.35
0.5
Basic EPS, GAAP
-0.18
-0.24
-72.48
-0.95
-0.54
-1.03
-0.07
- -
-0.38
-0.47
-0.33
1.26
0.91
0.92
0.69
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.27
-0.06
174.64
4.44
3.25
2.17
2
2
2.01
2.02
2
2
2
2
2
Book Value per Share
0.11
-0.14
110.8
1.91
1.42
1.85
1.92
1.87
1.59
1.33
1.61
2.22
3.1
4.05
3.28
Tangible Book Value per Share
87
87
- -
10
10
12
13
13
13
13
13
13
13
14
13
Basic Weighted Avg Shares
148
108
130
123
102
92
119
134
117
117
125
163
157
131
135
Sales/Revenue/Turnover
-0.4
-11.27
3.01
-5.03
-12.43
-10.88
-0.32
6.81
4.13
-6.36
2.5
2.86
8.71
4.77
6.02
Operating Margin (%)
3
5
7
8
9
6
6
4
3
6
7
8
8
7
8
Depreciation Expense
-3
-14
1
-6
-12
-10
-2
7
1
-7
2
3
11
5
7
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
25.65
21.91
- -
10.33
18.19
18.8
20.23
19.17
Effective Tax Rate (%)
-2.19
-12.87
0.7
-5.23
-11.41
-10.69
-1.33
4.94
1.16
-6.38
1.52
1.57
7.13
3.85
4.91
Profit Margin (%)
2
6
6
16
8
14
17
17
16
10
17
23
36
55
39
Working Capital
- -
17
2
3
2
1
1
- -
3
2
4
2
- -
- -
- -
LT Debt
24
7
42
50
37
41
39
45
50
44
46
49
59
75
61
Total Equity
- -
- -
- -
- -
- -
- -
- -
12.9
6.36
- -
4.26
6.17
19.82
7.42
10.92
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
19.41
4.75
- -
5.76
9.06
40.24
18.64
24.44
Return on Capital (%)
- -
- -
- -
-21.04
-29.2
-33.35
-6.27
26.14
5.36
-28.89
7.25
9.72
42.39
18.29
25.13
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
14
Market Capitalization
142
130
124

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
57
69
59
Cash, Cash Equivalents & STI
13
8
15
Accounts Receivable, Net
15
25
14
Inventories
24
31
26
Total Current Liabilities
21
31
20
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.21%
9.4%
25.94%
Free Cash Flow
1,661.9%
-100.73%
8.56%
Net Income, GAAP
-107.22%
-91.42%
-55%
Sales/Revenue/Turnover
1.91%
3.3%
-16.59%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
46
42
32
37
157
2025
35
31
35
- -
131
2026
31
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.27
0.23
0.14
0.2
0.85
2025
0.16
- -
0.1
- -
0.35
2026
0.06
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
New Horizon Health Limited (6606.HK)
Guided Therapeutics, Inc. (GTHP)
Pacific Biosciences of California, Inc. (PACB)
Coala-Life Group AB (publ) (COALA.ST)
DIH Holding US, Inc. Warrants (DHAIW)
Align Technology, Inc. (ALGN)
Business
Arcoma AB develops, produces, and provides complete digital radiography and radiology solutions globally, specializing in advanced digital X-ray systems that combine the latest imaging technology with technically advanced motorized positioning and ergonomic Scandinavian design. Its product portfolio includes digital X-ray systems such as the Precision series with autopositioning technology, the Intuition system featuring lightweight versatile design and auto-tracking, and ceiling suspensions optimized for high patient throughput and clinical workflow efficiency. The company serves hospitals, clinics, and imaging centers through OEM partners including Canon and Konica Minolta, as well as local distributors, with over 3,500 installations worldwide. Founded in 1989 and headquartered in Uppsala, Sweden, Arcoma focuses on patient-centric care by maximizing comfort and ease of use for radiologists and patients. In the last two years, Arcoma has notably completed a directed share issue raising approximately SEK 11.0 million (~EUR 1 million) led by Eiffel Investment Group, which became one of the company's largest shareholders, strengthening Arcoma's financial position and accelerating its growth strategy. The company plans to use the proceeds to expand sales resources, enhance product development and innovation, and actively pursue an acquisition strategy to consolidate its market position. Additionally, Arcoma won a significant procurement contract in Finland for up to six Precision i5 systems supplied to the HUS Medical Imaging Center, reflecting expanding operations within the Nordic region. These developments support Arcoma’s focus on improving profitability, market presence, and long-term value creation in the digital radiology industry. Arcoma operates primarily in the healthcare technology sector, targeting medical facilities requiring state-of-the-art digital imaging systems for radiology diagnostics. The company’s offerings are recognized for combining advanced digital imaging with specialized positioning technology, enabling efficient workflow and high patient throughput. Its strategic alliances with OEM partners and recent financial strengthening reinforce its position within international markets, particularly in Europe and North America. Arcoma’s business model leverages innovation, expansion, and partnerships to sustain its leadership in digital radiography since its founding and continued operations from Sweden.